z-logo
open-access-imgOpen Access
New Drugs 2021, Part 2
Author(s) -
Daniel A. Hussar
Publication year - 2021
Publication title -
nursing
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.187
H-Index - 23
eISSN - 1538-8689
pISSN - 0360-4039
DOI - 10.1097/01.nurse.0000791756.56705.dd
Subject(s) - medicine , drug , human immunodeficiency virus (hiv) , drug approval , pharmacology , covid-19 , intensive care medicine , virology , infectious disease (medical specialty) , disease
The second of a two-part series, this article describes eight recently approved drugs, including the first drug approved for the treatment of SARS-CoV-2, a first-in-class HIV attachment inhibitor, and a new intravenous injection indicated for the treatment of acute pain in adults for whom other treatments are ineffective.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here